Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
1,229 results
1229
Total Filings
$7040.4B
Total Raised
102
424B4 Offerings
321
ATM Programs
270
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2 | SVC | Real Estate | REIT - Hotel & Motel | $829M | Public Offering |
$1.36
floor
|
$6.40 | +370.6% | — | — | B. Riley, Oppenheimer | Service Properties Trust (SVC) is selling 416.7 million common shares at $1.20 per share to raise approximately $500 million, with net proceeds of $472.5 million after underwriting discounts for general corporate purposes. |
| Apr 2 | HOTH | Healthcare | Biotechnology | $11M | Public Offering |
$0.70
floor
|
$0.80 | +14.5% | 2.9M | $2M | — | HOTH sells 2,857,144 common shares at $0.70/share to institutional investors, raising approximately $2.0 million in gross proceeds. |
| Apr 2 | ADAG | Healthcare | Biotechnology | $105M | Public Offering | — | $2.80 | — | — | — | — | Adagene Inc. is selling 18,666,000 ADSs (representing 23.3 million ordinary shares) at $4.61 per ADS to raise approximately $86 million; proceeds will be used for general corporate purposes. |
| Apr 2 | CLDX | Healthcare | Biotechnology | $2.2B | Public Offering |
$31.26
floor
|
$32.37 | +3.6% | 10.3M | $323M | Cowen | Celldex Therapeutics (CLDX) is offering 10,345,000 common shares at $29.00 per share, raising $300 million gross proceeds for general corporate purposes. |
| Apr 2 | OSTX | Healthcare | Biotechnology | $74M | Public Offering |
$1.71
floor
|
$1.63 | -4.7% | 2.5M | $4M | — | OS Therapies is raising approximately $3.5 million selling 2.5 million common shares at $1.40 each plus accompanying warrants, with proceeds for general corporate purposes. |
| Apr 2 | TANH | Consumer Defensive | Household & Personal Products | $10M | Public Offering |
$0.30
floor
|
$14.55 | +4750.0% | — | — | — | Tantech Holdings Ltd is selling 7,166,671 Class A Common Shares at $0.30 per share in a registered direct offering to institutional investors, expected to raise approximately $2.15 million gross proceeds including concurrent warrant sales. |
| Apr 2 | INO | Healthcare | Biotechnology | $82M | Public Offering | — | $1.18 | — | — | — | Piper Sandler | # INO Offering Summary Inovio Pharmaceuticals is selling common stock with Series A and Series B warrants; specific share counts and pricing are redacted in this preliminary 424B5 filing dated April 1, 2026. |
| Apr 2 | INO | Healthcare | Biotechnology | $82M | Public Offering | — | $1.18 | — | 12.5M | — | Piper Sandler | Inovio Pharmaceuticals is selling 12.5 million common shares with Series A and B warrants at $1.40 per unit, raising $17.5 million for general corporate purposes. |
| Apr 2 | KYTX | Healthcare | Biotechnology | $383M | ATM |
$7.87
floor
|
$6.30 | -19.9% | — | — | Jefferies | Kyverna Therapeutics selling up to $100 million common stock at-the-market through Jefferies at $7.87/share; proceeds for general corporate purposes. |
| Apr 2 | CTNT | Consumer Cyclical | Auto - Dealerships | $51,393 | ATM |
$2.09
floor
|
$2.61 | +24.8% | — | — | — | Cheetah Net Supply Chain Service Inc. selling up to $70 million of Class A common stock at market prices through AC Sunshine Securities as sales agent; proceeds for general corporate purposes. |
| Apr 2 | CDTTW | — | — | — | ATM |
$5.10
floor
|
— | — | — | — | — | CDT increased its at-the-market offering from $3.6 million to $76.1 million in common stock at $5.10/share via A.G.P., with proceeds for general corporate purposes. |
| Apr 2 | ADAG | Healthcare | Biotechnology | $105M | Public Offering | — | $2.80 | — | — | — | — | # Offering Summary Adagene Inc. is offering American Depositary Shares (ADSs) at $3.92 per share on Nasdaq under ticker ADAG; the filing does not specify the number of shares or total proceeds. |
| Apr 2 | VIVS | Healthcare | Biotechnology | $502,937 | Public Offering |
$1.14
floor
|
$0.20 | -82.8% | 3.5M | $4M | — | Vivosim raises up to $4 million through best efforts offering of 3.5 million common shares/pre-funded warrants at $1.14 plus 5.3 million accompanying warrants; proceeds for general corporate purposes. |
| Apr 1 | ELAB | Healthcare | Biotechnology | $2M | Public Offering |
$20.10
floor
|
$3.37 | -83.2% | — | — | — | PMGC Holdings Inc. is selling $4.55 million in common stock to Streeterville Capital, LLC as the initial drawdown under a $20 million equity line of credit facility established September 23, 2025. |
| Apr 1 | CVKD | Healthcare | Biotechnology | $3M | Public Offering | — | $0.89 | — | 590K | — | — | Cadrenal Therapeutics amends existing warrants to purchase 571,430 common shares originally issued in November 2024 private placement, lowering exercise price from $16.50. |
| Apr 1 | SLNHP | — | — | — | ATM | — | — | — | — | — | — | Soluna Holdings Inc. (SLNH) is conducting an at-the-market offering of up to $500 million in common stock through H.C. Wainwright & Co., with proceeds for general corporate purposes. |
| Apr 1 | CLDX | Healthcare | Biotechnology | $2.2B | Public Offering |
$31.72
floor
|
$32.37 | +2.0% | — | — | Cowen | Cellectar Diagnostics (CLDX) is conducting a public offering of common stock at $31.72 per share (pricing details incomplete) on Nasdaq, with proceeds to fund unspecified corporate purposes. |
| Apr 1 | BFRGW | — | — | — | ATM | — | — | — | — | — | — | BullFrog AI Holdings, Inc. is selling up to $4.3 million in common stock at-the-market through BTIG, LLC as sales agent, with proceeds for general corporate purposes. |
| Apr 1 | FBLG | Healthcare | Biotechnology | $2M | Public Offering |
$1.32
floor
|
$1.16 | -12.5% | 1.0M | $1M | — | FibroBiologics is raising approximately $1.36 million by selling 1,028,788 common shares at $1.32 each, plus warrants, with proceeds for general corporate purposes. |
| Mar 31 | MTEKW | — | — | — | ATM | — | — | — | — | — | — | Maris Technology selling up to $3,007,329 in ordinary shares at-the-market through A.G.P./Alliance Global Partners; proceeds use not specified in excerpt. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →